Key Methodological Considerations in the Interpretation of the CONKO-007 Trial
Journal of Clinical Oncology · 10.07.2026 · 44 (20) · 1950-1951
DOI: 10.1200/jco-25-02156 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.07.2026. Verfasst von Orhun Akdogan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Orhun Akdogan, MD; Ahmet Ozet, MD; Ozan Yazıcı, MD; Nuriye Ozdemir, MD; and Osman Sütcüoglu, MD, Department of Medical Oncology, Gazi University, Ank…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Orhun Akdogan, MD; Ahmet Ozet, MD; Ozan Yazıcı, MD; Nuriye Ozdemir, MD; and Osman Sütcüoglu, MD, Department of Medical Oncology, Gazi University, Ankara, Turkey.
ORCID-Profile: Orhun Akdogan, Ahmet Ozet, Nuriye Ozdemir, Osman Sütcüoglu
Zitieren
APA
Akdogan, O., Ozet, A., Yazıcı, O., Ozdemir, N., & Sütcüoglu, O. (2026). Key Methodological Considerations in the Interpretation of the CONKO-007 Trial. Journal of Clinical Oncology, 44(20), 1950-1951. https://doi.org/10.1200/jco-25-02156
Vancouver
Akdogan O, Ozet A, Yazıcı O, Ozdemir N, Sütcüoglu O. Key Methodological Considerations in the Interpretation of the CONKO-007 Trial. Journal of Clinical Oncology. 2026;44(20):1950-1951. doi:10.1200/jco-25-02156
BibTeX
@article{Akdogan2026,
author = {Akdogan, Orhun and Ozet, Ahmet and Yazıcı, Ozan and Ozdemir, Nuriye and Sütcüoglu, Osman},
title = {Key Methodological Considerations in the Interpretation of the CONKO-007 Trial},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {20},
pages = {1950--1951},
doi = {10.1200/jco-25-02156}
}
EUVIMED